Compare FMC Corp (FMC) vs F.N.B. Corporation Common Stock (FNB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
FMC Corp vs F.N.B. Corporation Common Stock — how do they compare? FMC Corp trades at $8.05 (market cap $1.26B), while F.N.B. Corporation Common Stock trades at $16.96 (market cap $6.07B). The key difference: F.N.B. Corporation Common Stock is far larger — about 4.8× FMC Corp's market cap, and FMC Corp pays the higher dividend (3.96%). Which is the better fit depends on your goals — on Pluang, investors hold FMC Corp for 68 Days and F.N.B. Corporation Common Stock for 0 Days on average.
| FMC | FNB | |
|---|---|---|
Market Cap | $1.26B | $6.07B |
Volume | 3,029,236 | 5,600,609 |
Sector | Basic Materials | Financials |
52-Week High | $30.63 | $19.49 |
52-Week Low | $8.09 | $14.65 |
Typical Hold Time | 68 Days | 0 Days |
Enterprise Value | $5.06B | $10.61B |
Dividend Yield | 3.96% | 3.05% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FMC stock trades at $8.31, down slightly by 0.12% in the last session, with a bearish technical signal from moving averages. The company reported a net loss of $2.24 billion in 2025, with negative profit margins and ROE, though recent quarterly EPS beat estimates. Analyst consensus is mixed with a price target of $14.20, and recent news highlights regulatory progress for its herbicide in Brazil and a minority equity investment by Tessenderlo Group.
The outlook remains challenged by high debt and cyclical industry headwinds, but aggressive deleveraging efforts and new product filings offer potential upside. Key risks include persistent losses, volatile cash flows, and competitive pressures in the agricultural sector, requiring careful monitoring of earnings recovery and debt reduction progress.
FNB trades at $17.05, down 0.76% on the day, with a neutral technical signal. The stock shows solid fundamentals with a P/E of 10.15 and P/B of 0.89, indicating potential undervaluation. Recent earnings have been mixed, with Q2 2026 beating estimates but Q1 missing. Revenue remains stable at $1.77 billion for 2025, with a strong net income margin of 33.04%. Analyst sentiment is positive, with 13 buy ratings and a consensus price target of $20.80.
The outlook for FNB is cautiously optimistic, supported by strong profitability and a favorable analyst consensus. Key opportunities include potential upside to the price target and consistent dividend payments. Risks involve earnings volatility, as seen in recent quarters, and competitive pressures in the banking sector. Investors should weigh the attractive valuation against execution risks and market conditions.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About FMC Corp
FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.
Read more on FMC →About F.N.B. Corporation Common Stock
F.N.B. Corporation is a diversified financial services holding company headquartered in Pittsburgh, Pennsylvania, operating through its lead subsidiary, First National Bank of Pennsylvania. It provides commercial banking, consumer banking, wealth management, and insurance through more than 350 banking offices across seven states and Washington, D.C.
Read more on FNB →
